SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-060260
Filing Date
2007-08-08
Accepted
2007-08-08 16:42:48
Documents
4
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a07-18844_110q.htm 10-Q 678560
2 EX-31.1 a07-18844_1ex31d1.htm EX-31.1 11410
3 EX-31.2 a07-18844_1ex31d2.htm EX-31.2 12245
4 EX-32.1 a07-18844_1ex32d1.htm EX-32.1 11157
  Complete submission text file 0001104659-07-060260.txt   714861
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 071036175
SIC: 2835 In Vitro & In Vivo Diagnostic Substances